Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.250
-0.010 (-0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
1.292
+0.042 (3.38%)
After-hours: Apr 28, 2026, 5:10 PM EDT
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $159.53 million as of April 28, 2026. Its market cap has increased by 85.09% in one year.
Market Cap
159.53M
Enterprise Value
153.66M
1-Year Change
85.09%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $159.53M, an increase of 9.30%. That is a compound annual growth rate of 1.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 159.53M | -9.89% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 175.65M |
| Black Diamond Therapeutics | 170.15M |
| Jyong Biotech | 168.41M |
| ProQR Therapeutics | 163.31M |
| Spero Therapeutics | 158.62M |
| AN2 Therapeutics | 156.22M |
| Oramed Pharmaceuticals | 155.72M |
| Molecular Partners AG | 155.64M |